Drug profile · INN
lindane
GAMENE
lindane (GAMENE) is a gaba-a receptor negative allosteric modulator. Route of administration: topical. Current US regulatory status: approved.
Drug details — lindane
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
lindane (GAMENE) is a gaba-a receptor negative allosteric modulator. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor negative allosteric modulator
Primary target: GABA-A receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is lindane?
lindane (GAMENE) is a gaba-a receptor negative allosteric modulator. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for lindane?
GAMENE is a marketed brand name for lindane. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lindane?
lindane has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.